Its clearest effects are at the system level - shaping policy priorities, legitimising action, and providing a shared direction for the cancer control sector.
Two years into a 10-year reform agenda, the Plan's strongest influences are seen in improved national alignment and policy coherence, elevated attention to equity, strengthened collaboration across the sector, and the establishment of national infrastructure.
The Plan is shifting equity — particularly Aboriginal and Torres Strait Islander cancer outcomes — from a commitment dependent on individual champions toward a shared system-wide priority, moving beyond framing to actively resource Indigenous-led initiatives and partnerships.
Consumers reported the least visible change of any stakeholder group, suggesting that implementation and system-level reform have not yet translated into widespread, meaningful improvements in frontline experiences and outcomes.
There is broad but cautious optimism that current progress will lead to measurable population health impact over time, but extending the Plan's influence from policy and leadership circles to frontline services and community settings remains an important focus.
At the 2-year mark, the strongest effects are seen in influence, alignment and enabling conditions rather than direct service-level outcomes.
It is shaping policy priorities, supporting alignment between jurisdictions and sectors, and giving organisations a common reference point for strategy, planning, investment and advocacy.
The Plan has strengthened visibility, legitimacy and resourcing for equity-focused action, particularly for Aboriginal and Torres Strait Islander cancer outcomes, and is supporting Indigenous-led initiatives and partnerships.
Implementation partnerships, the ACCN and broader sector engagement are helping connect governments, cancer organisations, health services, researchers, consumers and priority population sectors around shared priorities.
National initiatives such as the National Optimal Care Pathways Framework, National Framework for Genomics in Cancer Control, National Cancer Data Framework, the Australian Comprehensive Cancer Network and Improving First Nations Cancer Outcomes initiatives provide infrastructure to support implementation over the life of the Plan.
Together, these effects show that the Plan is operating as a national system stewardship mechanism. The next challenge is translating system-level gains into consistent frontline delivery, measurable outcomes and improved experiences for people affected by cancer.
Since its launch in November 2023, the Plan has functioned primarily as an authorising and strategic framework, with its clearest effects at the system level — shaping policy priorities, legitimising action, and providing a shared direction for the cancer control sector.
“The Australian Cancer Plan acts as a framework that aligns with state and territory plans, setting strategic goals and concentrating national efforts on areas requiring coordinated action. Rather than duplicating existing plans, it complements them, leverages state initiatives, and prioritises national issues such as equity. Building on state and territory plans, it directs attention to where national coordination is most needed.” Union for International Cancer Control, 2026
For example, Chris O’Brien Lifehouse has explicitly aligned its organisational strategy and governance reporting to the Plan’s priorities, positioning its activities as contributing to national cancer control objectives. The Pancare Foundation has similarly aligned its organisational, research and advocacy strategies with the Plan’s strategic objectives. Cancer Council Australia has drawn on the Plan to inform policy and pre-budget submissions, using its priorities to frame national investment proposals. Ovarian Cancer Australia has also identified the Plan as an important influence on its strategic planning and service delivery direction. Sector alignment is expected to continue as implementation matures.
State/ Territory | Current plan | Title/ status | Indigenous cancer plan |
|---|---|---|---|
ACT | ✗ | No plan underway | ✗ |
NT | ✗ | In progress; anticipated 2026 | ✗ |
NSW | ✔ | NSW Cancer Plan 2022-2027. New plan also in progress | ✔ |
QLD | ✔ | QLD Cancer Strategy 2024 | ✔ |
SA | ✔ | SA Cancer Plan 2025-2029 | ✗ |
TAS | ✗ | In progress; anticipated 2026 | ✗ |
VIC | ✔ | VIC Cancer Plan 2024-2028 | ✔ |
WA | ✗ | In progress; timing unknown | ✗ |
While the Plan is functioning effectively as a shared organising framework, stakeholders identified an opportunity to strengthen how it directs investment across government – with some noting that funding decisions across the grants landscape do not always reflect Plan priorities. Strengthening alignment between the Plan and broader investment mechanisms - across Commonwealth, state and territory, and non-government funding streams – is an opportunity for the next phase.
Since its launch in November 2023, the Plan has functioned primarily as an authorising and strategic framework, with its clearest effects at the system level — shaping policy priorities, legitimising action, and providing a shared direction for the cancer control sector.
“The Australian Cancer Plan acts as a framework that aligns with state and territory plans, setting strategic goals and concentrating national efforts on areas requiring coordinated action. Rather than duplicating existing plans, it complements them, leverages state initiatives, and prioritises national issues such as equity. Building on state and territory plans, it directs attention to where national coordination is most needed.” Union for International Cancer Control, 2026
For example, Chris O’Brien Lifehouse has explicitly aligned its organisational strategy and governance reporting to the Plan’s priorities, positioning its activities as contributing to national cancer control objectives. The Pancare Foundation has similarly aligned its organisational, research and advocacy strategies with the Plan’s strategic objectives. Cancer Council Australia has drawn on the Plan to inform policy and pre-budget submissions, using its priorities to frame national investment proposals. Ovarian Cancer Australia has also identified the Plan as an important influence on its strategic planning and service delivery direction. Sector alignment is expected to continue as implementation matures.
State/ Territory | Current plan | Title/ status | Indigenous cancer plan |
|---|---|---|---|
ACT | ✗ | No plan underway | ✗ |
NT | ✗ | In progress; anticipated 2026 | ✗ |
NSW | ✔ | NSW Cancer Plan 2022-2027. New plan also in progress | ✔ |
QLD | ✔ | QLD Cancer Strategy 2024 | ✔ |
SA | ✔ | SA Cancer Plan 2025-2029 | ✗ |
TAS | ✗ | In progress; anticipated 2026 | ✗ |
VIC | ✔ | VIC Cancer Plan 2024-2028 | ✔ |
WA | ✗ | In progress; timing unknown | ✗ |
While the Plan is functioning effectively as a shared organising framework, stakeholders identified an opportunity to strengthen how it directs investment across government – with some noting that funding decisions across the grants landscape do not always reflect Plan priorities. Strengthening alignment between the Plan and broader investment mechanisms - across Commonwealth, state and territory, and non-government funding streams – is an opportunity for the next phase.
The most significant and consistently reported finding of the evaluation is the Plan’s elevation of equity as a central system priority, particularly Aboriginal and Torres Strait Islander cancer outcomes and equity for priority populations more broadly. This has positioned equity as a shared responsibility and increased its visibility across policy, funding, workforce, research, and service planning.
The Plan provides a nationally endorsed rationale and shared mandate for organisations to prioritise equity in ways that were previously more difficult to sustain without explicit national direction. By explicitly identifying equity as central to success and embedding it across the entirety of the Plan, it has helped shift equity from an optional or peripheral consideration to an increasingly collectively legitimised priority across the system. Stakeholders emphasised that this is shifting equity from a commitment dependent on individual champions toward a broadly shared, institutionally reinforced priority.
Aboriginal and Torres Strait Islander stakeholders described this as both validating and transformative. The Plan has provided legitimacy, shared language, and permission for conversations that were previously more contested or difficult to sustain. Stakeholders noted this has enabled a more integrated view of Aboriginal and Torres Strait Islander cancer care across the full continuum — from prevention and screening through to treatment, survivorship, and palliative care.
Critically, this has extended beyond framing – the Plan has prioritised and actively resourced Indigenous-led initiatives and partnerships, including through the First Nations Cancer Scholarship Program, the Partnerships for Culturally Safe Cancer Care Grant Program and the refreshed OCP for Aboriginal and Torres Strait Islander People with Cancer. Early signals of the positive impact of some of these funded initiatives are already emerging, with stakeholders pointing to growing Indigenous leadership and research capacity, stronger workforce pipelines, and deepening partnerships between Aboriginal and Torres Strait Islander community-controlled organisations and mainstream cancer services.
The Plan has catalysed new partnerships and strengthened existing ones, including across sectors beyond cancer control - mental health, disability, CALD communities, and Aboriginal and Torres Strait Islander health. Plan-enabled engagement beyond the cancer sector is influencing program design, resource allocation, and cross-disease collaboration, particularly around shared equity priorities that were previously fragmented.
The Implementation Partnership model and the ACCN were identified by stakeholders as key mechanisms supporting collaboration and partnerships. Collaboration has also extended into community settings through new multicultural and Indigenous partnerships. However, collaboration remains variable in depth and sustainability, and dependent in part on the availability of dedicated funding and formal partnership structures.
As detailed in Implementation progress (KEQ1), the Plan has established tangible national infrastructure — including frameworks, governance structures, partnerships, and system capabilities — that is expected to strengthen the foundations for delivery and accelerate progress toward its 5- and 10-year ambitions. Stakeholders consistently valued this infrastructure for enabling more connected, coordinated and nationally coherent cancer control, while identifying sustained investment and operationalisation at scale as the central challenge for the next phase.
Downstream changes at the service and patient level remain at an early stage and are not yet clearly evident. Consumers — the group the Plan ultimately serves — reported the least visible change of any stakeholder group. While broadly supportive of the Plan’s intent, consumer participants consistently distinguished between system-level activity and their lived experience, describing limited observable change in care delivery, low public awareness of the Plan, and inequities across cancer types, settings and population groups, drawing on their own lived experience and broader observations. This suggests a lag between system-level reform activity and consumer-visible change in experience and outcomes, consistent with what can reasonably be expected at this stage of a 10-year reform agenda, where system-level foundations typically precede measurable frontline change.
Stakeholders consistently identified a need to shift from system alignment toward implementation at scale — with clearer accountability, stronger delivery mechanisms, and more visible progress on equity and service improvement.
While there is strong support for the Plan and broad optimism that current system-level gains will translate into measurable population health impact over time, extending the Plan's influence from policy and leadership circles to frontline services and community settings will be an important focus for the next phase of implementation, consistent with stakeholder expectations regarding progression from system foundations to observable service-level impact.